Inactive Instrument

Rennova Health Inc Stock Nasdaq

Equities

Duration

Period

Style

RENNOVA HEALTH, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	20-07-24	AQ
RENNOVA HEALTH : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	20-07-17	AQ
RENNOVA HEALTH, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	20-07-08	AQ
RENNOVA HEALTH : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	20-06-29	AQ
RENNOVA HEALTH, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	20-06-16	AQ

Managers	Title	Age	Since
Darrell Peterson CEO	Chief Executive Officer	65	23-05-13
Gerard Dab CHM	Chairman	75	23-05-13
Sebastien Sainsbury IRO	Public Communications Contact	61	-

Members of the board	Title	Age	Since
Gerard Dab CHM	Chairman	75	23-05-13
Sharon Hollis CEO	Chief Executive Officer	47	11-06-30
Francisco Roca BRD	Director/Board Member	58	23-05-13

Sector

	1st Jan change	Capi.
SONIC HEALTHCARE LIMITED	-17.89%	8.25B
RADNET, INC.	+39.20%	3.58B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-39.11%	2.46B
SYNLAB AG	-8.06%	2.46B
DR. LAL PATHLABS LIMITED	-7.35%	2.38B
NEOGENOMICS, INC.	-12.61%	1.81B
FLEURY S.A.	-19.01%	1.55B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40.66%	1.21B
METROPOLIS HEALTHCARE LIMITED	+7.56%	1.11B